CMO demand jumped during the COVID-19 pandemic

Amy Baxter | | Health Exec | Leadership
doctor.jpg

Chief medical officer is the hottest job title in the healthcare field over the past few years, according to recent data that revealed a jump in demand during the COVID-19 pandemic. 

More than 2,900 jobs for CMOs were posted in 2022, according to Yahoo, citing data from Zip Recruiter. That’s compared to just 767 postings for the job title in 2019, and a record of 5,000 postings last year.

Interestingly, the need for CMOs spread across industries, with the healthcare industry seeing an obvious uptick in demand, but other industries as well. Non-healthcare companies typically required a clinician for operational and employee health management needs, Yahoo reported. 

Healthcare is a huge cost for companies, and managing employees’ health has created a new dynamic across industries that will stretch beyond the COVID-19 pandemic. Helping employees navigate the healthcare space can be beneficial for both employees and companies. 

See the full story below:

Demand for chief medical officer roles skyrocketed during pandemic

Related Content

Q&A: Bicycle Health CMO breaks down telehealth’s role in the opioid crisis
CVS appoints new CMO
Humana CMO on the role of AI in an integrated care landscape
Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

American Heart Association highlights importance of NIH as battle over Trump funding cuts continues
Cardiologist questions FDA’s approval process for high-risk medical devices
Gottlieb: Let’s not slap the label ‘medical device’ on AI software that only helps clinicians make care decisions
Why electrophysiologists needed a champion in Washington
Reimbursement update: What hospitals need to know about new Medicare payments for cardiac CT
FDA commissioner, a veteran cardiologist, highlights ongoing issues with US healthcare system

Around the web

Cardiovascular Business
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

Cardiovascular Business
Cardiologist questions FDA’s approval process for high-risk medical devices

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

Cardiovascular Business
FDA announces new recall of Johnson & Johnson heart pumps over safety concerns

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”